These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
152 related articles for article (PubMed ID: 26862302)
1. Inhibition of adenovirus multiplication by inosine pranobex and interferon α in vitro. Majewska A; Lasek W; Janyst M; Młynarczyk G Cent Eur J Immunol; 2015; 40(4):395-9. PubMed ID: 26862302 [TBL] [Abstract][Full Text] [Related]
2. [Inosine pranobex - cytotoxic activities and effect of on replication of human parainfluenza viruses (HPIV-2, HPIV-4), entroviruses (CA16, EV71) and adenoviruses (HAdV-2, HAdV-5) in vitro]. Majewska A; Lasek W; Młynarczyk G Med Dosw Mikrobiol; 2015; 67(2):107-13. PubMed ID: 26591662 [TBL] [Abstract][Full Text] [Related]
3. Interferon-α and inosine pranobex-mediated inhibition of reploication of human RNA viruses in vitro. Majewska A; Lasek W; Przybylski M; Dzieciqtkowski T; Mlynarczyk G Med Dosw Mikrobiol; 2016; 68(1):64-71. PubMed ID: 28146624 [TBL] [Abstract][Full Text] [Related]
4. IN VITRO INfIBITION OF HHV-1 REPLICATION BY INOSINE PRANOBEX AND INTERFERON-α. Majewska A; Lasek W; Janyst M; Młynarczyk G Acta Pol Pharm; 2016; 73(3):637-44. PubMed ID: 27476281 [TBL] [Abstract][Full Text] [Related]
5. Inosine pranobex is safe and effective for the treatment of subjects with confirmed acute respiratory viral infections: analysis and subgroup analysis from a Phase 4, randomised, placebo-controlled, double-blind study. Beran J; Šalapová E; Špajdel M; BMC Infect Dis; 2016 Nov; 16(1):648. PubMed ID: 27821093 [TBL] [Abstract][Full Text] [Related]
6. Genotoxicity and Mutagenicity of Inosine Pranobex. Tobólska S; Terpiłowska S; Jaroszewski J; Siwicki AK J Vet Res; 2018 Jun; 62(2):207-213. PubMed ID: 30364916 [TBL] [Abstract][Full Text] [Related]
7. Inosine Pranobex: A Key Player in the Game Against a Wide Range of Viral Infections and Non-Infectious Diseases. Sliva J; Pantzartzi CN; Votava M Adv Ther; 2019 Aug; 36(8):1878-1905. PubMed ID: 31168764 [TBL] [Abstract][Full Text] [Related]
8. Inosine pranobex. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy. Campoli-Richards DM; Sorkin EM; Heel RC Drugs; 1986 Nov; 32(5):383-424. PubMed ID: 2431857 [TBL] [Abstract][Full Text] [Related]
9. Influence of Inosine Pranobex on Cell Viability in Normal Fibroblasts and Liver Cancer Cells. Tobólska S; Terpiłowska S; Jaroszewski J; Siwicki AK J Vet Res; 2018 Jun; 62(2):215-220. PubMed ID: 30364913 [TBL] [Abstract][Full Text] [Related]
10. Multicenter randomized study of inosine pranobex versus acyclovir in the treatment of recurrent herpes labialis and recurrent herpes genitalis in Chinese patients. You Y; Wang L; Li Y; Wang Q; Cao S; Tu Y; Li S; Bai L; Lu J; Wei Z; Chen W; Hao F J Dermatol; 2015 Jun; 42(6):596-601. PubMed ID: 25819042 [TBL] [Abstract][Full Text] [Related]
11. Generation of Human Embryonic Stem Cell-Derived Lung Organoids for Modeling Infection and Replication Differences between Human Adenovirus Types 3 and 55 and Evaluating Potential Antiviral Drugs. Zhao S; Wu X; Tan Z; Ren Y; Li L; Ou J; Lin Y; Song H; Feng L; Seto D; Wu J; Zhang Q; Rong Z J Virol; 2023 May; 97(5):e0020923. PubMed ID: 37120831 [TBL] [Abstract][Full Text] [Related]
12. Study of the inhibition of histamine release by inosine pranobex. Ziesche R; Eichelberg D; Schmutzler W Agents Actions; 1987 Apr; 20(3-4):172-3. PubMed ID: 2440263 [TBL] [Abstract][Full Text] [Related]
13. The efficacy of inosine pranobex in preventing the acquired immunodeficiency syndrome in patients with human immunodeficiency virus infection. The Scandinavian Isoprinosine Study Group. Pedersen C; Sandström E; Petersen CS; Norkrans G; Gerstoft J; Karlsson A; Christensen KC; Håkansson C; Pehrson PO; Nielsen JO N Engl J Med; 1990 Jun; 322(25):1757-63. PubMed ID: 1693173 [TBL] [Abstract][Full Text] [Related]
14. Inhibition of Human Adenovirus Replication by the Importin α/β1 Nuclear Import Inhibitor Ivermectin. King CR; Tessier TM; Dodge MJ; Weinberg JB; Mymryk JS J Virol; 2020 Aug; 94(18):. PubMed ID: 32641484 [TBL] [Abstract][Full Text] [Related]
15. Comparative studies of inosine pranobex and acyclovir. Mindel A Am J Med; 1988 Aug; 85(2A):7-9. PubMed ID: 2457315 [TBL] [Abstract][Full Text] [Related]
16. [Immunological and clinical study on therapeutic efficacy of inosine pranobex]. Gołebiowska-Wawrzyniak M; Markiewicz K; Kozar A; Derentowicz P; Czerwińska-Kartowicz I; Jastrzebska-Janas K; Wacławek J; Wawrzyniak ZM; Siwińska-Gołebiowska H Pol Merkur Lekarski; 2005 Sep; 19(111):379-82. PubMed ID: 16358878 [TBL] [Abstract][Full Text] [Related]
17. Adenovirus Infection of Human Enteroids Reveals Interferon Sensitivity and Preferential Infection of Goblet Cells. Holly MK; Smith JG J Virol; 2018 May; 92(9):. PubMed ID: 29467318 [TBL] [Abstract][Full Text] [Related]
18. Treatment of alopecia totalis with a combination of inosine pranobex and diphencyprone compared to each treatment alone. Berth-Jones J; Hutchinson PE Clin Exp Dermatol; 1991 May; 16(3):172-5. PubMed ID: 1718636 [TBL] [Abstract][Full Text] [Related]
19. Immunomodulatory effects of inosine pranobex on cytokine production by human lymphocytes. Lasek W; Janyst M; Wolny R; Zapała Ł; Bocian K; Drela N Acta Pharm; 2015 Jun; 65(2):171-80. PubMed ID: 26011933 [TBL] [Abstract][Full Text] [Related]
20. HAdV-C6 Is a More Relevant Challenge Virus than HAdV-C5 for Testing Antiviral Drugs with the Immunosuppressed Syrian Hamster Model. Toth K; Spencer JF; Ying B; Tollefson AE; Wold WSM Viruses; 2017 Jun; 9(6):. PubMed ID: 28608847 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]